Gastrointestinal epithelial and mucosal surface adhesion sites

Gastrointestinal epithelial and mucosal surface adhesion sites refer to the specialized molecular interfaces on the lining of the digestive tract where cells, microbes, and therapeutic agents interact. These sites are primarily composed of the glycocalyx, a dense network of mucins such as MUC2, and various cell-surface receptors like integrins and cadherins that maintain tissue integrity (UniProt, 2024). Their primary biological function is to provide a selective barrier that facilitates nutrient absorption while preventing the entry of pathogens and toxins (NIH, 2023). In conditions like peptic ulcer disease, gastritis, and inflammatory bowel disease, these adhesion sites are often damaged or exploited by pathogens like Helicobacter pylori to colonize the host (PubMed, 2022). Pharmacological intervention at these sites typically involves mucosal protectants, such as sucralfate or bismuth subsalicylate, which bind to exposed proteins or form a physical coating to promote healing (StatPearls, 2023). Additionally, anti-adhesion therapies are being explored to competitively inhibit the binding of harmful bacteria to these epithelial surfaces (PubChem, 2024). Understanding the topography and molecular composition of these sites is essential for developing targeted drug delivery systems that can adhere to the GI tract for prolonged therapeutic effect.

Other names

GI mucosal surfaceGut epithelial adhesion receptorsMucosal barrier sitesGastrointestinal glycocalyxIntestinal mucosal interface

Formation of a protective physical barrier over damaged mucosa, competitive inhibition of pathogen attachment to epithelial receptors, and stimulation of local prostaglandin and bicarbonate production to enhance mucosal integrity.